Medpace Reference Laboratories supplier risk profile Q1-2026: Mexico-based pharma imports, B-grade compliance assessment.
Medpace Reference Laboratories imported 96 shipments in Q1 2026 across 3 suppliers, all based in Mexico (100% of shipments). The importer's primary sourcing focuses on pharmaceutical products and clinical supplies, with HS Chapter 30 (pharmaceutical products) accounting for approximately 63% of shipments. Top suppliers include Internacional Latinoamericana de Servicios with 47 shipments and RPS Research Servicios with 39 shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Medpace Reference Laboratories recorded zero sanctions watchlist matches in Q1 2026. No suppliers in the import footprint register forced-labor exposure under UFLPA proximity screening.
3 distinct tier-1 suppliers in Q1 2026
| INTERNACIONAL LATINOAMERICANA DE SERVICIOS | Mexico | 47 |
| RPS RESEARCH SERVICIOS | Mexico | 39 |
| RS CLINICAL RESEARCH SOLUTIONS MEXICO | Mexico | 10 |
Share of Q1 2026 inbound shipments by source country
3 tier-2 + 27 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.